Combined HER2 Targeted Therapy Without Chemotherapy Will Likely Benefit Certain Breast Cancer Patients

Is the era of targeted therapy for breast cancer at hand? It could be, said experts at the Lester and Sue Smith Breast Center at Baylor College of Medicine - at least for a certain population of women. In a report that appears online in the Journal of Clinical Oncology, the researchers have shown that a subset of breast cancer patients who have tumors overexpressing a protein called the human epidermal growth factor receptor 2 (HER-2 positive) may benefit from a combination of targeted treatments that zero in on the breast cancer cells themselves...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Breast Cancer Source Type: news